ArticleMedicine2025
Identification of key biomarkers and immune infiltration in the co-occurrence of oral lichen planus and Hashimoto's thyroiditis by integrated bioinformatics analysis.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Melissa officinalis extract selectively suppresses STAT1 signaling in oral epithelial cells.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing evidence have suggested the co-occurrence of oral lichen planus (OLP) and Hashimoto thyroiditis (HT), the underlying mechanism remains unclear. The aim of our study was to investigate co-expressed differentially expressed genes (co-DEGs) of OLP and HT, elucidate the mechanisms responsible for co-occurrence of OLP and HT. The expression profiles of GSE52130 and GSE29315 were downloaded from the Gene Expression Omnibus database to obtain DEGs between disease group and healthy control group by GEO2R. Enrichment analysis of co-DEGs were performed by Metascape platform. The protein-protein interaction (PPI) network of co-DEGs were developed utilizing the STRING database. Subsequently, CIBERSORT was utilized to evaluate the infiltration of immune cells in OLP and HT. Finally, enzyme-linked immunosorbent assay and quantitative real-time PCR were conducted to verify the key genes in clinic samples. A total of 76 co-DEGs were recognized. Enrichment analysis demonstrated that these co-DEGs focused primarily on cytokine signaling in immune system. The 10 most firmly related genes among co-DEGs were identified from the PPI network. We found that immune cell infiltration associated with VCAM1 expression was correlated with OLP and HT. The top 3 co-DEGs (CXCL12, CXCL10, and VCAM1) in PPI network were verified in OLP and HT samples. VCAM1 may be closely related pathogenesis of co-occurrence of OLP and HT, and represents a new candidate molecular marker of the occurrence and progression of OLP and HT. Moreover, immune cell infiltration associated with VCAM1 expression plays an important role in the coexistence of OLP and HT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.